Details of the Target
General Information of Target
Target ID | LDTP01816 | |||||
---|---|---|---|---|---|---|
Target Name | Complement C5 (C5) | |||||
Gene Name | C5 | |||||
Gene ID | 727 | |||||
Synonyms |
CPAMD4; Complement C5; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]
|
|||||
3D Structure | ||||||
Sequence |
MGLLGILCFLIFLGKTWGQEQTYVISAPKIFRVGASENIVIQVYGYTEAFDATISIKSYP
DKKFSYSSGHVHLSSENKFQNSAILTIQPKQLPGGQNPVSYVYLEVVSKHFSKSKRMPIT YDNGFLFIHTDKPVYTPDQSVKVRVYSLNDDLKPAKRETVLTFIDPEGSEVDMVEEIDHI GIISFPDFKIPSNPRYGMWTIKAKYKEDFSTTGTAYFEVKEYVLPHFSVSIEPEYNFIGY KNFKNFEITIKARYFYNKVVTEADVYITFGIREDLKDDQKEMMQTAMQNTMLINGIAQVT FDSETAVKELSYYSLEDLNNKYLYIAVTVIESTGGFSEEAEIPGIKYVLSPYKLNLVATP LFLKPGIPYPIKVQVKDSLDQLVGGVPVTLNAQTIDVNQETSDLDPSKSVTRVDDGVASF VLNLPSGVTVLEFNVKTDAPDLPEENQAREGYRAIAYSSLSQSYLYIDWTDNHKALLVGE HLNIIVTPKSPYIDKITHYNYLILSKGKIIHFGTREKFSDASYQSINIPVTQNMVPSSRL LVYYIVTGEQTAELVSDSVWLNIEEKCGNQLQVHLSPDADAYSPGQTVSLNMATGMDSWV ALAAVDSAVYGVQRGAKKPLERVFQFLEKSDLGCGAGGGLNNANVFHLAGLTFLTNANAD DSQENDEPCKEILRPRRTLQKKIEEIAAKYKHSVVKKCCYDGACVNNDETCEQRAARISL GPRCIKAFTECCVVASQLRANISHKDMQLGRLHMKTLLPVSKPEIRSYFPESWLWEVHLV PRRKQLQFALPDSLTTWEIQGVGISNTGICVADTVKAKVFKDVFLEMNIPYSVVRGEQIQ LKGTVYNYRTSGMQFCVKMSAVEGICTSESPVIDHQGTKSSKCVRQKVEGSSSHLVTFTV LPLEIGLHNINFSLETWFGKEILVKTLRVVPEGVKRESYSGVTLDPRGIYGTISRRKEFP YRIPLDLVPKTEIKRILSVKGLLVGEILSAVLSQEGINILTHLPKGSAEAELMSVVPVFY VFHYLETGNHWNIFHSDPLIEKQKLKKKLKEGMLSIMSYRNADYSYSVWKGGSASTWLTA FALRVLGQVNKYVEQNQNSICNSLLWLVENYQLDNGSFKENSQYQPIKLQGTLPVEAREN SLYLTAFTVIGIRKAFDICPLVKIDTALIKADNFLLENTLPAQSTFTLAISAYALSLGDK THPQFRSIVSALKREALVKGNPPIYRFWKDNLQHKDSSVPNTGTARMVETTAYALLTSLN LKDINYVNPVIKWLSEEQRYGGGFYSTQDTINAIEGLTEYSLLVKQLRLSMDIDVSYKHK GALHNYKMTDKNFLGRPVEVLLNDDLIVSTGFGSGLATVHVTTVVHKTSTSEEVCSFYLK IDTQDIEASHYRGYGNSDYKRIVACASYKPSREESSSGSSHAVMDISLPTGISANEEDLK ALVEGVDQLFTDYQIKDGHVILQLNSIPSSDFLCVRFRIFELFEVGFLSPATFTVYEYHR PDKQCTMFYSTSNIKIQKVCEGAACKCVEADCGQMQEELDLTISAETRKQTACKPEIAYA YKVSITSITVENVFVKYKATLLDIYKTGEAVAEKDSEITFIKKVTCTNAELVKGRQYLIM GKEALQIKYNFSFRYIYPLDSLTWIEYWPRDTTCSSCQAFLANLDEFAEDIFLNGC |
|||||
Target Type |
Successful
|
|||||
Target Bioclass |
Other
|
|||||
Subcellular location |
Secreted
|
|||||
Function |
Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.; [C5a anaphylatoxin]: Derived from proteolytic degradation of complement C5, C5a anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation.
|
|||||
TTD ID | ||||||
Uniprot ID | ||||||
DrugMap ID | ||||||
Ensemble ID | ||||||
HGNC ID | ||||||
ChEMBL ID |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
N1 Probe Info |
![]() |
C724(0.00); R723(0.00) | LDD0245 | [1] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Enzyme
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EBP) | EBP family | Q15125 | |||
Kell blood group glycoprotein (KEL) | Peptidase M13 family | P23276 |
Transporter and channel
Transcription factor
Immunoglobulin
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Killer cell immunoglobulin-like receptor 3DL3 (KIR3DL3) | Immunoglobulin superfamily | Q8N743 |
Other
The Drug(s) Related To This Target
Approved
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Sb12 | Antibody | D2RTQ0 | |||
Sky59 | Antibody | D1O9XQ | |||
Zimura | Oligonucleotide | DH3YK4 | |||
Coversin | Recombinant protein | DYG0W5 | |||
Abp959 | Small molecular drug | DRQ18X | |||
Ra101495 | . | D0W8BO |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Lfg-316 | Antibody | D04HOT | |||
Nnc-0151-0000-0000 | Antibody | D0J4PM | |||
Pozelimab | Antibody | D4XBR9 | |||
Tesidolumab | Antibody | D76INB | |||
Ifx-1 | . | D05YWJ |
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Arc-1905 | Aptamer | D08FMR | |||
Medi7814 | . | D0H0ZV | |||
Rev-576 | . | D0H6VZ |
Preclinical
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Sand-5 | . | D0B1DA |
Investigative
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Vilobelimab | . | DB16416 | |||
Zilucoplan | . | DB15636 |
Discontinued
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Pexelizumab | Antibody | D0P6MB | |||
Cgs-32359 | . | D0I1BX | |||
Mp-435 | . | D0H0ZU |